FIELD: medicine, pharmaceutics.
SUBSTANCE: what is presented is a diuretic of the aquaretic group that is 4-nitro-phenyl-O-D-glucopyranoside. The agent may be used both to treat greater and lesser circulation congestions caused by cardiac failure, and to intensify water release thereby helping to reduce oedemas. The diuretic agent has high and low saluretic activity unlike the existing diuretics and expands the range of products of synthetic origin possessing diuretic activity.
EFFECT: agent is applicable for treating a number of cardiovascular diseases accompanied by excessive hydration and developing oedema syndrome.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DIURETIC AGENT | 2012 |
|
RU2500407C2 |
| DIURETIC AGENT | 2012 |
|
RU2487714C1 |
| MEDICATION, POSSESSING DIURETIC ACTION | 2012 |
|
RU2517091C2 |
| AGENT HAVING DIURETIC AND ANTI-INFLAMMATORY ACTION | 2013 |
|
RU2522925C1 |
| MEDICATION POSSESSING DIURETIC ACTIVITY | 2009 |
|
RU2416404C1 |
| USE OF HYPEROZIDE AS A DIURETIC, SALURETIC AND CREATININURETIC AGENT | 2022 |
|
RU2802832C1 |
| DIURETIC | 2009 |
|
RU2408367C1 |
| USE OF QUERCETIN AS A DIURETIC, SALURETIC AND CREATININURETIC AGENT | 2022 |
|
RU2802833C1 |
| USE OF DIHYDROQUERCETIN AS A DIURETIC, SALURETIC AND CREATININURETIC AGENT | 2022 |
|
RU2802874C1 |
| USE OF PINOSTROBIN AS DIURETIC AND CREATINURETIC AGENT | 2023 |
|
RU2816948C1 |
